Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,882 | 644 | 98.6% |
| Gift | $178.16 | 3 | 1.2% |
| Travel and Lodging | $35.20 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,895 | 210 | $0 (2024) |
| Allergan, Inc. | $1,152 | 64 | $0 (2020) |
| Gilead Sciences, Inc. | $828.44 | 40 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $771.35 | 53 | $0 (2023) |
| Janssen Biotech, Inc. | $763.21 | 39 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $684.24 | 49 | $0 (2024) |
| Merck Sharp & Dohme LLC | $500.33 | 21 | $0 (2023) |
| PFIZER INC. | $487.37 | 6 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $468.54 | 4 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $441.81 | 23 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $921.88 | 38 | ABBVIE INC. ($259.97) |
| 2023 | $1,041 | 45 | ABBVIE INC. ($532.47) |
| 2022 | $1,930 | 66 | ABBVIE INC. ($793.93) |
| 2021 | $1,491 | 77 | AbbVie Inc. ($707.70) |
| 2020 | $851.94 | 41 | AbbVie Inc. ($417.31) |
| 2019 | $2,411 | 114 | AbbVie, Inc. ($726.04) |
| 2018 | $2,946 | 121 | AbbVie, Inc. ($710.20) |
| 2017 | $3,501 | 146 | AbbVie, Inc. ($746.95) |
All Payment Transactions
648 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: LIVER DISEASE | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $2.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $31.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: VIROLOGY | ||||||
| 10/10/2024 | Ipsen Biopharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $21.63 | General |
| 10/10/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2024 | ALBIREO PHARMA, INC. | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Rare Disease | ||||||
| 09/12/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $145.01 | General |
| Category: Rare Disease | ||||||
| 08/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/16/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/19/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/27/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 181 | 243 | $88,675 | $24,649 |
| 2022 | 7 | 369 | 459 | $120,375 | $33,787 |
| 2021 | 8 | 597 | 731 | $229,820 | $53,749 |
| 2020 | 8 | 495 | 577 | $170,908 | $38,272 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 145 | $29,000 | $13,624 | 47.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $17,875 | $7,106 | 39.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $23,100 | $2,332 | 10.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $18,700 | $1,586 | 8.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 122 | 188 | $19,920 | $11,992 | 60.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 78 | $11,555 | $6,995 | 60.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 32 | 32 | $27,700 | $4,298 | 15.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $16,860 | $2,981 | 17.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 28 | 28 | $6,400 | $2,825 | 44.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 32 | 32 | $21,280 | $2,347 | 11.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,500 | $2,086 | 46.4% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 61 | 61 | $12,160 | $261.70 | 2.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 168 | 293 | $30,765 | $19,749 | 64.2% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 54 | 54 | $42,900 | $6,441 | 15.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 64 | 64 | $14,400 | $6,368 | 44.2% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 43 | 43 | $34,300 | $6,006 | 17.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 72 | 73 | $45,920 | $4,738 | 10.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 35 | 35 | $7,875 | $4,166 | 52.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 20 | 20 | $26,000 | $3,903 | 15.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 22 | $2,310 | $1,843 | 79.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2021 | 123 | 127 | $25,350 | $535.00 | 2.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 113 | 150 | $15,841 | $8,456 | 53.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 96 | 128 | $13,407 | $7,143 | 53.3% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 46 | 46 | $37,400 | $5,798 | 15.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 48 | 48 | $10,825 | $4,522 | 41.8% |
About Dr. Galen Huang, MD
Dr. Galen Huang, MD is a Gastroenterology healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316971765.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Galen Huang, MD has received a total of $15,095 in payments from pharmaceutical and medical device companies, with $921.88 received in 2024. These payments were reported across 648 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($14,882).
As a Medicare-enrolled provider, Huang has provided services to 1,642 Medicare beneficiaries, totaling 2,010 services with total Medicare billing of $150,456. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Riverside, CA
- Active Since 07/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316971765
Products in Payments
- STELARA (Biological) $1,190
- CREON (Drug) $1,008
- LINZESS (Drug) $972.76
- VIBERZI (Drug) $951.80
- XIFAXAN (Drug) $906.42
- MAVYRET (Drug) $687.77
- Humira (Biological) $622.27
- Creon (Drug) $597.51
- ZEPOSIA (Drug) $352.58
- DIFICID (Drug) $328.10
- OCALIVA (Drug) $295.88
- ENTYVIO (Biological) $287.91
- Amitiza (Drug) $259.40
- Mavyret (Drug) $252.86
- Talicia (Drug) $250.96
- FARXIGA (Drug) $226.37
- Epclusa (Drug) $204.95
- HUMIRA (Biological) $203.30
- IQIRVO (Drug) $187.67
- TOUJEO (Drug) $179.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Riverside
Anil Garde, Md, MD
Gastroenterology — Payments: $41,788
Vinod Mishra, Md, MD
Gastroenterology — Payments: $13,964
Dr. Amer Malik, Md, MD
Gastroenterology — Payments: $9,292
Steven Moss, Md, MD
Gastroenterology — Payments: $8,788
Dr. Philip Chen, Md, MD
Gastroenterology — Payments: $8,665
Dr. Amit Srivastava, M.d, M.D
Gastroenterology — Payments: $4,803